Third, while most studies demonstrate that PD-L1+ TAMs are immunosuppressive and show pro-tumor phenotypes, other studies suggest that baseline PD-L1+ TAMs do not contribute to suppression of anti-tumor T cell responses and in some cases are associated with better prognosis [177,178,179,180]. The gene discussed is CD274; the disease is neoplasm.